HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Donald C Goff Selected Research

Cycloserine (Seromycin)

1/2017D-cycloserine in Schizophrenia: New Strategies for Improving Clinical Outcomes by Enhancing Plasticity.
3/2014d-Cycloserine augmentation of cognitive remediation in schizophrenia.
9/2012D-cycloserine: an evolving role in learning and neuroplasticity in schizophrenia.
9/2011D-cycloserine facilitation of cognitive behavioral therapy for delusions in schizophrenia.
12/2008Once-weekly D-cycloserine effects on negative symptoms and cognition in schizophrenia: an exploratory study.
4/2005A six-month, placebo-controlled trial of D-cycloserine co-administered with conventional antipsychotics in schizophrenia patients.
7/2002D-Cycloserine added to risperidone in patients with primary negative symptoms of schizophrenia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Donald C Goff Research Topics

Disease

107Schizophrenia (Dementia Praecox)
08/2021 - 03/2002
28Psychotic Disorders (Schizoaffective Disorder)
01/2022 - 01/2005
7Mental Disorders (Mental Disorder)
01/2022 - 08/2006
7Insulin Resistance
06/2019 - 01/2005
7Cognitive Dysfunction
05/2015 - 04/2005
6Diabetes Mellitus
04/2009 - 01/2005
5Inflammation (Inflammations)
05/2021 - 12/2009
5Hypertension (High Blood Pressure)
12/2016 - 05/2005
4Metabolic Syndrome (Dysmetabolic Syndrome X)
07/2009 - 12/2005
4Cardiovascular Diseases (Cardiovascular Disease)
07/2009 - 02/2005
4Weight Gain
04/2009 - 05/2005
3Atrophy
05/2021 - 01/2018
3Body Weight (Weight, Body)
06/2019 - 05/2005
3Obesity
04/2009 - 05/2005
3Hyperlipidemias (Hyperlipidemia)
04/2009 - 09/2005
2COVID-19
01/2022 - 12/2021
2Drug-Related Side Effects and Adverse Reactions
01/2020 - 09/2014
2Substance-Related Disorders (Drug Abuse)
12/2016 - 12/2003
2Treatment-Resistant Schizophrenia
01/2013 - 05/2007
2Sleep Initiation and Maintenance Disorders (Insomnia)
01/2010 - 02/2008
2Fatigue
12/2009 - 02/2008
2Neurobehavioral Manifestations
12/2009 - 04/2005
2Overweight
04/2009 - 05/2005
2Weight Loss (Weight Reduction)
04/2009 - 05/2005
2Memory Disorders (Memory Loss)
01/2009 - 07/2008
2Coronary Disease (Coronary Heart Disease)
10/2008 - 12/2005
1Infections
01/2022
1Cerebral Cortical Thinning
01/2021
1Central Nervous System Diseases (CNS Diseases)
01/2020
1Neurodevelopmental Disorders
10/2019
1Disease Progression
01/2017
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2016

Drug/Important Bio-Agent (IBA)

45Antipsychotic Agents (Antipsychotics)IBA
01/2022 - 03/2002
19Clozapine (Clozaril)FDA LinkGeneric
06/2019 - 02/2004
10Olanzapine (Zyprexa)FDA Link
06/2019 - 03/2002
9Glucose (Dextrose)FDA LinkGeneric
06/2019 - 01/2005
8Biomarkers (Surrogate Marker)IBA
05/2021 - 06/2013
8Insulin (Novolin)FDA Link
06/2019 - 01/2005
8N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2017 - 04/2002
8Risperidone (Risperdal Consta)FDA LinkGeneric
03/2015 - 07/2002
7Cycloserine (Seromycin)FDA Link
01/2017 - 07/2002
7N-Methylaspartate (NMDA)IBA
01/2017 - 04/2002
7Pharmaceutical PreparationsIBA
04/2016 - 12/2003
6Dopamine (Intropin)FDA LinkGeneric
09/2015 - 04/2002
6Folic Acid (Vitamin M)FDA LinkGeneric
05/2013 - 09/2004
6Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA
04/2011 - 05/2007
5Bupropion (Wellbutrin)FDA LinkGeneric
01/2013 - 03/2004
5NicotineFDA Link
01/2013 - 02/2008
4Aripiprazole (Abilify)FDA Link
05/2021 - 04/2009
4Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2021 - 03/2006
4KetamineFDA LinkGeneric
10/2020 - 04/2002
4LipidsIBA
06/2019 - 08/2006
4Glycine (Aminoacetic Acid)FDA LinkGeneric
09/2012 - 04/2002
4CholesterolIBA
08/2006 - 09/2005
3CitalopramFDA LinkGeneric
05/2021 - 01/2019
3Glutamic Acid (Glutamate)FDA Link
10/2020 - 03/2002
3Polytetrafluoroethylene (Teflon)FDA Link
10/2020 - 02/2013
3Biological ProductsIBA
10/2019 - 12/2008
3Varenicline (Chantix)FDA Link
01/2014 - 06/2008
3ziprasidone (Geodon)FDA Link
08/2013 - 04/2007
3Lamotrigine (Lamictal)FDA LinkGeneric
11/2009 - 09/2005
3Quetiapine Fumarate (Seroquel)FDA Link
10/2009 - 05/2006
2Protons (Proton)IBA
01/2021 - 03/2002
2Antidepressive Agents (Antidepressants)IBA
01/2021 - 01/2019
2Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA
01/2018 - 09/2008
2Hemoglobins (Hemoglobin)IBA
12/2016 - 04/2007
2EndocannabinoidsIBA
01/2016 - 10/2015
2davunetideIBA
06/2013 - 04/2012
2Modafinil (Provigil)FDA Link
08/2011 - 12/2009
2CytokinesIBA
04/2010 - 07/2007
2C-Reactive ProteinIBA
12/2009 - 01/2007
2Triglycerides (Triacylglycerol)IBA
08/2008 - 09/2005
2Nicotinic AgonistsIBA
07/2008 - 02/2008
2Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
07/2008 - 02/2008
1AntibodiesIBA
01/2022
1Valproic Acid (Depakote)FDA LinkGeneric
01/2022
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2022
1Paliperidone PalmitateFDA Link
01/2022
1D-Amino-Acid Oxidase (D-Amino Acid Dehydrogenase)IBA
08/2021
1Silver Sulfadiazine (SSD)FDA LinkGeneric
01/2021
1metabotropic glutamate receptor 2IBA
10/2020
1Particulate MatterIBA
01/2020
1Glycine Dehydrogenase (Decarboxylating)IBA
10/2019
1Telmisartan (Micardis)FDA Link
06/2019
1DNA (Deoxyribonucleic Acid)IBA
01/2018
1Biogenic Amines (Biogenic Amine)IBA
01/2016
1GlucocorticoidsIBA
01/2016
1Investigational DrugsIBA
01/2016
1lumateperoneIBA
01/2016
1CannabidiolIBA
10/2015
1CannabinoidsIBA
10/2015
1Histamine (Histamine Dihydrochloride)FDA Link
05/2015
1GSK239512IBA
05/2015

Therapy/Procedure

9Therapeutics
10/2019 - 12/2007
3Secondary Prevention
12/2016 - 01/2013
3Aftercare (After-Treatment)
01/2014 - 02/2005
2Drug Therapy (Chemotherapy)
01/2019 - 01/2014
2Injections
01/2018 - 12/2016
2Tobacco Use Cessation Devices
01/2013 - 08/2007
2Polypharmacy
06/2004 - 09/2003